Similar results were obtained in the same mouse model with intravenous injection of CXCL7 antibodies (Fig. S4E–G), revealing the therapeutic potential of using neutralizing antibodies against CXCL7 to treat breast cancer metastasis. Here, PPBP is linked to breast cancer.